Zepbound 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F0YM8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,195
Award facts
- Contract value 100% obligated
- $24,195.07 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $24.2K firm fixed price delivery order to AmerisourceBergen Drug Corp for Zepbound 2.5 mg/0.5 ml pen injectors on December 17, 2025, with completion scheduled for December 18, 2025. This non-set-aside competitive award was issued from the company's place of performance in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1B global pharmaceutical support vehicle that runs through December 2026 and enables the company to supply a comprehensive range of pharmaceuticals and medical supplies to military healthcare systems worldwide.
Zepbound is a semaglutide-based medication used for weight management in eligible patients. This award reflects AmerisourceBergen's established role as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. As a major pharmaceutical and healthcare solutions provider, the company maintains an extensive portfolio of federal contracts with DLA covering various therapeutic categories including diabetes medications, neurological treatments, pain management pharmaceuticals, and specialized medical supplies. The firm fixed pricing structure and non-set-aside status indicate this award was competitively evaluated among qualified vendors.
Quick answers
Who was awarded contract SPE2DR26F0YM8?
SPE2DR26F0YM8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 17, 2025.
How much is contract SPE2DR26F0YM8 worth?
The government has obligated $24,195 on SPE2DR26F0YM8.
Is contract SPE2DR26F0YM8 an order under another contract?
Yes. SPE2DR26F0YM8 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F0YM8 competed?
The extent of competition for SPE2DR26F0YM8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award